Clinical Trials Sponsored by 301 Hospital

Total 101011 results

Beijing 302 Hospital

Not yet recruiting

Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

Hematological Malignancies | Graft-versus-host Disease
Beijing 302 Hospital

Recruiting

Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal Diseases (Endo-mmfi)

Gastrointestinal Disease

China
Beijing 302 Hospital

Recruiting

HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC

Breast Cancer

China
Beijing 302 Hospital

Not yet recruiting

Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy

Hepatocellular Carcinoma Non-resectable | Conversion
Beijing 302 Hospital

Recruiting

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Stereotactic Body Radiation Therapy | Transcatheter Arterial Chemoembolization | Large HCC Patients

China
Beijing 302 Hospital

Recruiting

CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis

Hepatocellular Carcinoma

China
Beijing 302 Hospital

Recruiting

Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis

Decompensated Liver Cirrhosis

China
Beijing 302 Hospital

Completed

36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

Drug-induced Liver Injury,Chronic

China
Beijing 302 Hospital

Withdrawn

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

Primary Biliary Cirrhosis

China
Beijing 302 Hospital

Completed

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

Human Immunodeficiency Virus | Immunodeficiency
Beijing 302 Hospital

Unknown

Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill

Drug-Induced Liver Injury

China
Beijing 302 Hospital

Unknown

RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure

Liver Failure | Hepatitis B | Alcoholic Liver Disease

China
Beijing 302 Hospital

Unknown

A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial

Chronic Hepatitis B | Liver Fibrosis

China
Beijing 302 Hospital

Unknown

Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance

Evidence of Liver Transplantation

China
Beijing 302 Hospital

Unknown

Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis

Autoimmune Hepatitis

China
Beijing 302 Hospital

Unknown

Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
Beijing 302 Hospital

Not yet recruiting

Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis

HER2-negative Breast Cancer Brain Metastases

China
Beijing 302 Hospital

Recruiting

Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib

Breast Cancer

China
Beijing 302 Hospital

Recruiting

Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC

Liver Neoplasms

China
Beijing 302 Hospital

Recruiting

Outcome of Tucidinostat-Based Therapy in HR+ Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitor

Breast Cancer

China
Beijing 302 Hospital

Recruiting

Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV

COVID-19 | Vaccine | People Living With HIV

China
Beijing 302 Hospital

Recruiting

Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer

COVID-19 | Vaccine | Patients With Cancers

China
Beijing 302 Hospital

Not yet recruiting

A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients

SARS-CoV2 Infection
Beijing 302 Hospital

Terminated

Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients

Hepatitis B, Chronic

China
Beijing 302 Hospital

Unknown

Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection

Pneumonia Caused by Human Coronavirus (Disorder)

China
Beijing 302 Hospital

Unknown

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients

Human Immunodeficiency Virus | Disorder of Immune Reconstitution

China
Beijing 302 Hospital

Completed

Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis

Liver Cirrhosis

China
Beijing 302 Hospital

Unknown

Surveillance for Early Liver Injuries Caused by Runzao Zhiyang Capsule.

Drug-Induced Liver Injury

China
Beijing 302 Hospital

Unknown

Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.

Drug-Induced Liver Injury

China
Beijing 302 Hospital

Unknown

Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection

Human Immunodeficiency Virus

China
Beijing 302 Hospital

Recruiting

The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients

Chronic Hepatitis B

China
Beijing 302 Hospital

Recruiting

Clinical Trial of Metal-Reinforced Teeth Designed for Endoscopic Clips

Pilot Study | Clips

China
Beijing 302 Hospital

Recruiting

HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC

Breast Cancer

China
Beijing 302 Hospital

Not yet recruiting

Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study

HR+/HER2- Advanced Breast Cancer

China
Beijing 302 Hospital

Recruiting

Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer

TNBC - Triple-Negative Breast Cancer

China
Beijing 302 Hospital

Not yet recruiting

Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia

Refractory Acute Myeloid Leukemia | Minimal Residual Disease | Relapsed Acute Myeloid Leukemia
Beijing 302 Hospital

Recruiting

Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer

COVID-19 | Vaccine Reaction | Patients With Cancer

China
Beijing 302 Hospital

Recruiting

COVID-19 Vaccines in Patients With Chronic Liver Disease

Liver Disease Chronic

China
Beijing 302 Hospital

Not yet recruiting

Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

HBeAg Positive Chronic Hepatitis B

China
Beijing 302 Hospital

Recruiting

Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE

Stereotactic Body Radiation Therapy | Transcatheter Arterial Chemoembolization | Small Hepatocellular Carcinoma

China
Beijing 302 Hospital

Active, not recruiting

Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B

Chronic Hepatitis B

China
Beijing 302 Hospital

Completed

On the Cyberknife Dose Fraction of Liver Cancer Treatment

CyberKnife Radiosurgery

China
Beijing 302 Hospital

Completed

Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI

Drug-induced Liver Injury,Chronic

China
Beijing 302 Hospital

Unknown

Surveillance for Early Liver Injuries Caused by Yangxue Shengfa Capsule.

Drug-Induced Liver Injury

China
Beijing 302 Hospital

Unknown

Surveillance for Early Liver Injuries Caused by Xianlin Gubao Granule

Drug-Induced Liver Injury

China
Beijing 302 Hospital

Unknown

Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.

Drug-Induced Liver Injury

China
Beijing 302 Hospital

Unknown

Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B

Chronic Hepatitis B

China
Beijing 302 Hospital

Unknown

Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection

Chronic Hepatitis C

China
Beijing 302 Hospital

Unknown

OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI

HCC
Beijing 302 Hospital

Unknown

The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion

Chronic Hepatitis B

China

3

Subscribe